US EditionRayonier to Present at Upcoming Investor Conferences
TransMedics will engage investors with presentations at two major healthcare conferences, highlighting its advancements in organ transplant technology.
- On Feb. 17, 2026, TransMedics Group, Inc. announced from Andover, Mass. that it will participate in two upcoming investor conferences.
- TransMedics describes itself as a medical-technology company transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, and its management will engage investors at two upcoming conferences.
- The TD Cowen 46th Annual Health Care Conference will feature TransMedics management in a fireside chat on Sunday, March 2, 2026, at 1:50 p.m. EST.
- TransMedics will present virtually at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on Monday, March 17, 2026, at 10:00 a.m. EST for investors and analysts.
- Issued yesterday, Feb. 17, 2026, the announcement places TransMedics' near-term Nasdaq-listed firm appearances at two investor conferences next month.
22 Articles
22 Articles
The Hamilton Spectator
The Toronto StarMedicenna Therapeutics Announces Participation in Upcoming Conferences
TORONTO and HOUSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer, autoimmune, and inflammatory diseases is pleased to announce…
Bennington Banner
TransMedics to Present at Upcoming March Investor Conferences
ANDOVER, Mass., Feb. 17, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in…
New Hamburg independent
OrangevilleCricut to Present at Upcoming Investor Conference
SOUTH JORDAN, Utah, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cricut, Inc. (“Cricut”) (NASDAQ: CRCT), the creative technology company that has brought a connected platform for making to millions of users worldwide, today announced that members of its management team are…
INOVIO to Present at Cancer, Investor Conferences
PLYMOUTH MEETING, PA — INOVIO (Nasdaq: INO) announced that it will participate in several upcoming scientific and investor conferences in February and March. The biotechnology company said it will present at the American Association for Cancer Research Immuno-Oncology Conference in Los Angeles on February 18 during Poster Session A from 7:30 p.m. to 10 p.m. PT. The poster presentation is titled “Treatment of RRP with DNA immunotherapy INO-3107 i…
Coverage Details
Bias Distribution
- 50% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
